Page 17 - Pharma Companies

Natco Pharma's board approves acquiring 1% in its Canadian subsidiary

Drug major Natco Pharma on Friday said its board has approved acquiring about 1 per cent stake in its Canadian subsidiary

Will supply more doses of AstraZeneca vaccine to UK later, says Serum

Senior officials in New Delhi confirmed that there was no ban on exports from India, and no plans to do so either.

PE/VC investments gather pace in February: Here're the top 5 deals

The top 10 investments accounted for 69 per cent of the total deal value, according to Aurum Equity Partners

India emerges global manufacturing hub for Covid-19 vaccine Sputnik V

Gland Pharma to make 252 mn doses, Hetero 100 mn doses, Strides may also join the fray

Four IPOs get investors' backing; chemical firm and jeweler make their mark

Anupam Rasayan's Rs 760-crore offer was subscribed 45 times; Kalyan Jewellers' IPO was subscribed 60 per cent on the first day of the issue

Price talks on Russia's Sputnik V Covid-19 vaccine yet to kick off

Rs 150/dose not ceiling price; cost to be fixed individually

Activists, drug groups split over suspending Covid-19 shot patents

Some 100 nations have expressed support, as has Doctors Without Borders (MSF) and World Health Organization head Tedros Adhanom Ghebreyesus.

Parikh family, former promoters of Zandu, exits pharma business

Sells stake in drug firm ZCL to PE firm Advent for Rs 1,600 cr

Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand

Cipla stock went up by almost 3 per cent on Tuesday

Cipla receives USFDA nod for nasal spray for treating migraine attacks

Drug major Cipla on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) for Sumatriptan Nasal Spray, indicated for the treatment of migraine attacks

Russian, Chinese hacking groups target pharma companies for Covid-19 data

Singapore-based cyber intelligent firm Cyfirma says 15 active hacking campaigns are underway; US, UK and Japan among a slew of other nations also on cybercriminals' target list

To end reliance on China, Indian pharma firms go local for raw materials

Though India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for half of its API needs in 2019

Can re-engineer Covaxin to beat South African variant: Bharat Biotech

Other vaccine makers, such as Hyderabad-based Biological E, too, have started working on different strains.

Pfizer-BioNTech vaccine stops Covid-19 spread by 90%, says study

This provides the first indication that the immunisation will curb transmission

As Covid-19 cases fall, so do sales of favipiravir and remdesivir drugs

While remdesivir is an injectable drug which is administered in hospital settings, antiviral drug favipiravir is given orally

Novavax, Serum Institute plans to supply 1.1 billion doses to COVAX

Novavax has signed a memorandum of understanding (MoU) in this regard with Gavi, the Vaccine Alliance.

States shying away from administering Bharat Bio's Covid-19 vaccine Covaxin

A month on, 21 states and UTs have not administered a single shot of the vaccine

Pharma's 3Q profitability improvement starts to taper off: Ind-Ra

The ratings agency does not expect Indian pharmaceutical companies to sustain the healthy operating margins reported during 3Q FY21 and 9M FY21

AstraZeneca Pharma India Q3 net profit declines 21% at Rs 21 crore

Drug firmAstraZeneca Pharma India on Monday reported a 21 per cent decline in net profit at Rs 21.05 crore for the quarter ended in December

Corporate air travel takes wing on economic revival, low Covid-19 cases

Online travel portals and airlines say the demand from companies is being led by essential services sectors like pharmaceutical, oil and gas, and power